Research & Development



  平叟是一個見過大風浪的人,猛虎進來的時候雖然驚駭,見老虎對他沒有惡意,很快就恢復了往日的那種平和的模樣。   第四天的時候,太宰才跟著雲瑯離開。青青草在线视频青青草视频   不等她跑到山洞,就看見一頭斑斕猛虎從山洞里竄了出來,而他家小郎,正騎在老虎的身上,用力的掐著老虎的脖子。青青草视频免费观看   一點決斷都沒有!   雲瑯搖頭道︰“沒有,比我以前監工的時候還差,這些鐵料用來打造農具有余,用來制造兵刃就是笑話了。”青青草在线   正在收拾殘羹剩飯的小蟲迷惑的道︰“早上吃完飯就沒見老虎。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo